The morbidity and disability at pneumoconiosis (PC) combined with chronic obstructive pulmonary disease (COPD) have been studied for correct assess of the severity and course direction of those diseases, for development of their effective treatment and prevention.
It is determined that at the present stage the prevalence of PC combined with COPD is 15.6%, the disability is characterized by frequent, prolonged complications, which lead to high rates of temporary disability, insignificant duration of remission during a calendar year, to high percentage of persistent incapacity. In most cases, category III disability used to be assigned to the patients. The unsatisfactory quality of remission was in 6.7 to 17.6% of the patients significantly worsening the quality of their life. The data obtained determine the need for special attention to this category of patients, the developing and implementing efficient methods for diagnostics and treatment of PC combined with COPD for improvement of life quality in patients.